findmyKOL
Clinical trialNCT02471820CompletedPhase 2Interventional

Lenalidomide & Adriamycin & Dexamethasone (RAD) in Newly Diagnosed, Multiple Myeloma Patients

SponsorMeletios A. DimopoulosEnrollment45Multiple Myeloma
View the registry record on ClinicalTrials.gov

Summary

The registered summary isn't in our current data snapshot. Read it on the ClinicalTrials.gov record ↗. Why? →

Investigators

The overall officials registered on this study. Names that resolve to a findmyKOL profile link to it; the rest are shown as registered.

A profile link is shown only when the registered name resolves to a person record with a confident, namesake-checked match; ambiguous names stay unlinked.

Sites

4 registered facilities, with the per-site recruitment status where the registry publishes one. ClinicalTrials.gov does not publish per-site enrollment counts.

Greece
  • General Hospital of Athens "alexandra"

    Athens, Attica, Greece

  • General Hospital of Athens "g. Gennimatas"

    Athens, Attica, Greece

  • University General Hospital of Patras

    Pátrai, Patra, Greece

  • Theageneio Anticancer Hospital of Thessaloniki

    Thessaloniki, Thessaloniki, Greece

Site investigator names are published by ClinicalTrials.gov only while a study recruits, so completed studies list sites without them.

Drugs studied

The drug and biological interventions registered on this study, normalized to their RxNorm ingredient where possible.

Linked drugs open the directory filtered to KOLs working with them.clinicaltrials.gov

Registration & key dates

Registry attributes as recorded on the ClinicalTrials.gov study record.

Start
30 Nov 2014
Primary completion
31 Jul 2016
Completion
31 Jul 2016
Last update posted
17 Oct 2016
Registered enrollment
45
Registry id
NCT02471820

Cross-registrations

EU-CTR / CTIS (EudraCT)2011-001499-20

Source: ClinicalTrials.gov, via the CTTI AACT database, data as of 12 Jul 2026. Registry facts are shown as registered by the study sponsor; findmyKOL does not interpret them.